Home

James R. Kasinger, General Counsel and Secretary: Crispr Therapeutics CRSP Sell · Filed 03/24

Trade details

Type
Insider sale
Amount
$148,853.96
Shares · price
3,182 sh · $46.78 a share
Held after
94,308 sh
Trade date
26/03/23
Filed
26/03/24
Days to filing
1 days

Sold 3.3% of holdings

Share of holding sold
3.3%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 02/21~04/22

James R. Kasinger's recent trades

  • James R. Kasinger

    Sell10b5-1 planCrispr Therapeutics

    $626.5K

    Filed 09/24

  • James R. Kasinger

    Planned sale10b5-1 planCrispr Therapeutics

    $626.5K

    Filed 09/22

  • James R. Kasinger

    SellCrispr Therapeutics

    $166.5K

    Filed 03/17

  • James R. Kasinger

    SellCrispr Therapeutics

    $147.8K

    Filed 03/12

  • James R. Kasinger

    SellCrispr Therapeutics

    $111K

    Filed 02/20